急性严重性结肠炎患者的代谢压力 - 一个单中心队列研究
Mathias Redsted1,2, Magnus Grønhøj1,2, Louise Dalsgaard Brøchner1,2
1Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
Frontiers in endocrinology
|November 28, 2024
概括
患有急性严重性结肠炎 (ASUC) 的患者在入院和类固醇治疗期间会出现显著的胰岛素抵抗. 虽然在三周后情况有所改善,但胰岛素抵抗仍然存在,突出显示了易受损害的代谢状态.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
背景情况:
- 急性严重性结肠炎 (ASUC) 涉及全身炎症和超级代.
- 对ASUC的高剂量类固醇治疗可以加剧新陈代谢问题,如高血糖症和胰岛素抵抗.
- 在ASUC中,炎症和类固醇对胰岛素抵抗的联合影响尚未完全理解.
研究的目的:
- 量化ASUC患者在住院和出院后的代谢压力,包括胰岛素耐药性.
- 为了研究炎症和类固醇治疗在ASUC相关的代谢变化之间的协同作用.
主要方法:
- 成年ASUC患者的单中心队列研究.
- 使用Truelove和Witt的标准进行评估.
- 测量包括间接热量计,生物电阻分析和HOMA-IR在基线和3周后续.
主要成果:
- 15名ASUC患者完成了这项研究.
- 在入院时显著升高HOMA-IR和空腹血葡萄糖.
- 在3周的随访期内,HOMA-IR和葡萄糖水平显著降低 (p<0.004).
- 静止能量消耗或人体测量没有显著变化.
结论:
- ASUC患者表现出显著的胰岛素耐药性,特别是在入院和高剂量类固醇治疗期间.
- 代谢脆弱性在ASUC的急性阶段是明显的.
- 胰岛素耐药性虽然有所改善,但与对照人群相比,在出院三周后仍然较高.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
317
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
317
Inflammatory Bowel Disease I: Ulcerative Colitis
138
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
138
Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120
Chronic Bowel Disorders: Introduction
388
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
388
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
89
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
89
Inflammatory Bowel Disease II: Crohn's Disease
185
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
185


